Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 ZIEKTE NETWERK REGISTRATIE PROJECTS INLOGGEN
 
 
  
The Project - Constitution -
--->Nieuws
[-]Het Project
--->Sponsor
--->[-]Executive Committee
--->Arnesen
--->Blumenstein
--->Burgunder
--->Craufurd
--->Humbert
--->Jones
--->Kremer
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Public Documents
--->[+]Writing Committee Strategic ...
--->[+]Scientific and Bioethics Advis...
--->Centrale Coördinatie
--->Landelijke Coördinatie
--->Fellowship Programme
--->[-]Constitution
--->Article 1
--->Article 2
--->Article 3
--->Article 4
--->Article 5
--->Article 6
--->Article 7
--->Article 8
--->Article 9
--->Article 10
--->Article 11
--->Article 12
--->Documents
--->[-]Voting/Nomination
--->[+]Members
[-]Landen
--->[+]Oostenrijk
--->[+]België
--->[+]Czech Republic
--->[+]Denemarken
--->[+]Finland
--->[+]Frankrijk
--->[-]Duitsland
--->Coördinatie
--->Huntington Vereniging
--->Standard of Care
--->Aachen
--->Berlin
--->Bochum
--->Bonn
--->Dresden
--->Dinslaken
--->Düsseldorf
--->Erlangen
--->Freiburg
--->Hamburg
--->Hannover
--->HH-Heiligenhafen
--->Itzehoe
--->Marburg-Uni
--->[-]Lübeck
--->Marburg-PKH
--->Mainz
--->Munich
--->München-LMU
--->Münster
--->Rostock
--->Taufkirchen
--->Ulm
--->[+]Würzburg
--->[+]Ireland
--->[+]Italië
--->[+]Nederland
--->[+]Norwegen
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[+]Spanje
--->[+]Zweden
--->[+]Zwitserland
--->[+]Groot-Brittannië
--->[+]Outside Europe
[-]Werkgroepen
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[-]Environmental Modifiers
--->[+]Dates
--->[+]Meetings
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[-]Symptomatic Research
--->[+]Dates
--->[+]Meetings
--->[+]Young Adults
[+]Events
[-]Communicatie
--->Contact Opnemen
--->Chat Rooms
--->Mailinglijsten - public
--->Newsletter
--->Vacatures

THE CONSTITUTION

OF THE

EUROPEAN HUNTINGTON´S DISEASE NETWORK



Table of Contents

ARTICLE 1 NAME; MISSION AND PRINCIPLES
ARTICLE 2 ORGANIZATION
ARTICLE 3 MEMBERSHIP
ARTICLE 4 EXECUTIVE COMMITTEE; CHAIR AND CO-CHAIR
ARTICLE 5 STANDING EHDN COMMITTEES
ARTICLE 6 ADMINISTRATION
ARTICLE 7 MEETINGS OF MEMBERS
ARTICLE 8 EHDN ENDORSEMENT OF PROJECTS
ARTICLE 9 ACCESS TO EHDN DATA AND BIOMATERIALS
ARTICLE 10  PUBLICATION AND AUTHORSHIP
ARTICLE 11 ETHICS AND CONFLICTS-OF-INTEREST
ARTICLE 12 AMENDMENTS; DISSOLUTION; EFFECTIVE DATE
  
about us | privacy statement | disclaimer | terms of use